Atlas Trials

Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)

Clinical trial NCT02463305 · WITHDRAWN

Trial details

NCT number
NCT02463305
Sponsor
University of Colorado, Denver
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Colitis, Ulcerative
Start date
2022-08-01
Primary completion
2023-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.